Current Genmab A/S forecasts and price targets in November 2026

Ø Analyst Price Targets
331.14 USD
-39.43 %
Median
343.83 USD
-37.11 %
Max
3,167.85 USD
Min
1,313.00 USD
Last Price
546.72 USD
Buy
16
Hold
8
Sell
2

The average target price for Genmab A/S is 331.14 USD. (-39.43 % below the current price)

The median price target of Genmab A/S is 343.83 USD.

Stock analysts from many renowned investment banks are closely examining the Genmab A/S stock. They conclude their professional Genmab A/S stock analyses with a clear recommendation for the Genmab A/S stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.

BuyHoldSellØ Analyst Price Targets
2026-04-011782—
2026-03-011682331.14 USD
2026-02-011682340.63 USD
2026-01-011692322.97 USD
2025-12-011782318.05 USD
2025-11-011862320.59 USD

Genmab A/S Stock Forecast 2026: Revenue & Earnings Estimates

Analysts expect the following revenue and earnings for Genmab A/S in the coming fiscal years:

Fiscal yearRevenueNet IncomeEarnings per share
2026e4.49 B USD740.00 M USD11.00 USD
2027e5.43 B USD1.10 B USD16.37 USD
2028e6.93 B USD1.76 B USD26.17 USD
Genmab A/S Stock → Genmab A/S Dividend →